TOSOH BIOSCIENCE, INC. FDA Inspection Record

FEI 3005529799 · Inspections, Form 483s, warning letters and import refusals

TOSOH BIOSCIENCE, INC. is an FDA-registered facility (FEI 3005529799) located in Grove City, OH, US. RegDataLab tracks 6 FDA inspections and 2 compliance actions at this facility.

What FDA found at this site

Latest inspection
Oct 11, 2019: Voluntary Action Indicated (VAI)
Inspections on record
6 (3 OAI, 2 VAI, 1 NAI)
Last OAI inspection
Jun 28, 2016
Warning letters
2 listed by FDA for this FEI, latest Aug 5, 2016
Recalls as the recalling firm
23, latest Jun 12, 2026

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Oct 11, 2019Voluntary Action Indicated (VAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Production processes (21 CFR 820.70(a))
Oct 16, 2018No Action Indicated (NAI)Lack of or inadequate procedures (21 CFR 820.100(a))
Nonconforming product, Lack of or inadequate procedures (21 CFR 820.90(a))
Servicing - Lack of or inadequate procedures (21 CFR 820.200(a))
Lack of or inadequate process validation (21 CFR 820.75(a))
Jun 28, 2016Official Action Indicated (OAI)Quality audits - Lack of or inadequate procedures (21 CFR 820.22)
Lack of or inadequate procedures (21 CFR 820.100(a))
Investigation of device failures (21 CFR 820.198(c))
Maintenance schedule, Lack of or inadequate schedule (21 CFR 820.70(g)(1))
and 2 more
Jun 17, 2011Voluntary Action Indicated (VAI)Design transfer - Lack of or inadequate procedures (21 CFR 820.30(h))
Design changes - Lack of or Inadequate Procedures (21 CFR 820.30(i))
Design history file (21 CFR 820.30(j))
Lack of or inadequate procedures (21 CFR 820.100(a))
and 2 more
Aug 5, 2010Official Action Indicated (OAI)No citations listed
May 27, 2010Official Action Indicated (OAI)No citations listed

Recalls

Showing the 10 most recent of 23 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jun 12, 2026Class IIZ-2746-2026ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of…
The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer…
Aug 7, 2020Class IIZ-2967-2020Tosoh Bioscience AIA- PACK HCG Calibrator Set-In Vitro Diagnostic for BHCG Part number… and 1 more product
Decreased stability for five (5) lots of Calibrator Sets and Calibration Verification Test Sets, resulting in a decrease measured…
May 22, 2020Class IIZ-2423-2020AIA-900 Analyzer, Part no. 022930, UDI 04560189283992
The Substrate Monitoring System in the AIA-900 Analyzer did not detect an empty substrate bottle. The issue may lead to erroneous…
Jan 10, 2020Class IIZ-1420-2020AIA-360 Automated Immunoassay Analyzer, Product Code 019945
A display screen software issue on the analyzer causes the display to freeze when display screen is touched at the same time as a command…
Nov 30, 2018Class IIZ-0671-2019AIA-PACK B12 (Vitamin B12) is designed for IN VITRO DIAGNOSTIC USE ONLY for the… and 5 more products
Potential for fluorescein interference to cause inaccurately elevated results for certain Tosoh AIA assays
Oct 5, 2018Class IIZ-0469-2019AIA-900 Analyzer, Product code 022930, 022930R
Tosoh Bioscience has become aware of a potential issue with the pickup arm and pickup arm motor on the AIA-900 Analyzer. If the pickup arm…
Oct 5, 2018Class IIZ-0509-2019AIA-900 Automated Immunoassay Analyzer, product code 022930 /022930R Product…
Tosoh Bioscience has become aware of a potential issue with the axis base of the turntable rotation drive motor on the AIA-900 Analyzer. If…
Oct 5, 2018Class IIIZ-0601-2019Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the…
Tosoh Bioscience has become aware of potential degradation of HbA1c control lot # 7055 before the 60-days product stability claim. If…
Sep 28, 2018Class IIZ-0475-2019AIA-2000 Analyzer, Model Nos. AIA-2000LA, AIA-2000ST - Product Usage: The AIA-2000 is…
There is a possibility that the liquid suction pump on some AIA-2000 analyzers may not perform as intended and cause an insufficient volume…
Sep 28, 2018Class IIZ-0485-2019Tosoh AIA-900 immunoassay Analyzer
A software issue may cause the liquid volume detection entries for 2nd and 3rd reagent bottles to be overwritten with the data from the 1st…

FDA record score

24 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 22, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

27 records behind this number
RecordDatePoints x age weightAdds
Class II recall Z-2746-2026, this FEI as the recalling firmJun 12, 20264 x 14
Inspection classified VAIOct 11, 20196 x 0.251.5
Class II recall Z-2967-2020, this FEI as the recalling firmAug 7, 20204 x 0.251
Class II recall Z-2423-2020, this FEI as the recalling firmMay 22, 20204 x 0.251
Class II recall Z-1420-2020, this FEI as the recalling firmJan 10, 20204 x 0.251
Class II recall Z-0671-2019, this FEI as the recalling firmNov 30, 20184 x 0.251
Class II recall Z-0469-2019, this FEI as the recalling firmOct 5, 20184 x 0.251
Class II recall Z-0509-2019, this FEI as the recalling firmOct 5, 20184 x 0.251
Class II recall Z-0475-2019, this FEI as the recalling firmSep 28, 20184 x 0.251
Class II recall Z-0485-2019, this FEI as the recalling firmSep 28, 20184 x 0.251
Class II recall Z-0599-2019, this FEI as the recalling firmSep 28, 20184 x 0.251
Class II recall Z-0559-2019, this FEI as the recalling firmAug 23, 20184 x 0.251
Class II recall Z-3244-2018, this FEI as the recalling firmJul 13, 20184 x 0.251
Class II recall Z-2745-2018, this FEI as the recalling firmJun 6, 20184 x 0.251
Class II recall Z-1809-2018, this FEI as the recalling firmMar 5, 20184 x 0.251
Class II recall Z-2065-2018, this FEI as the recalling firmMar 5, 20184 x 0.251
Class II recall Z-0825-2018, this FEI as the recalling firmFeb 13, 20184 x 0.251
Class II recall Z-0602-2019, this FEI as the recalling firmSep 28, 20174 x 0.251
Class II recall Z-0491-2018, this FEI as the recalling firmJun 11, 20174 x 0.251
Class II recall Z-0613-2019, this FEI as the recalling firmMar 22, 20174 x 0.251
Warning letter on FDA's dashboard, which does not show close-outsAug 5, 201610 years or older, so it adds no points0
Inspection classified OAIJun 28, 201610 years or older, so it adds no points0
Class II recall Z-1187-2021, this FEI as the recalling firmFeb 23, 201210 years or older, so it adds no points0
Inspection classified VAIJun 17, 201110 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsJan 18, 201110 years or older, so it adds no points0
Inspection classified OAIAug 5, 201010 years or older, so it adds no points0
Inspection classified OAIMay 27, 201010 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 22, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 22, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 22, 2026Newest record Nov 13, 2026Current
Warning letter textNov 22, 2026Newest record Nov 17, 2026Current
Recalls (Enforcement Report)Nov 22, 2026Newest record Nov 18, 2026Current
Form 483s and inspection documentsNov 18, 2026Newest record Nov 17, 2026Current
Import refusalsNov 22, 2026Newest record Nov 12, 2026Current

Reviewing TOSOH BIOSCIENCE, INC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check TOSOH BIOSCIENCE, INC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Tosoh Bioscience Inc
Location
Grove City, OH (US)
Source
device

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.